Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial

MLA

Linda W. Moore, et al. “Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Double-Blind, Randomized, Placebo-Controlled Trial.” American Journal of Transplantation, vol. 19, June 2019, pp. 1831–37. EBSCOhost, https://doi.org/10.1111/ajt.15328.

APA

Linda W. Moore, A O Gaber, Duc T. Nguyen, Richard J. Knight, Samantha A. Kuten, William L. Musick, Edward A. Graviss, & Samir J. Patel. (2019). Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial. American Journal of Transplantation, 19, 1831–1837. https://doi.org/10.1111/ajt.15328

Chicago

Linda W. Moore, A O Gaber, Duc T. Nguyen, Richard J. Knight, Samantha A. Kuten, William L. Musick, Edward A. Graviss, and Samir J. Patel. 2019. “Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Double-Blind, Randomized, Placebo-Controlled Trial.” American Journal of Transplantation 19 (June): 1831–37. doi:10.1111/ajt.15328.